ABOUT

Aptis Partners is a global life science consultancy founded in 2001 dedicated to helping our clients optimize pipeline asset management. Our work forms the basis of commercial success across all aspects of advancing your pipeline: strategic partnerships, portfolio prioritization, clinical trial strategy, and managing the ever-present uncertainty and risk.

Projects range from identifying the optimal markets for platform technologies with potential value across a variety of product or market applications, to attribute optimization and successful competitive positioning.

Years of experience and devotion to objectivity make Susan and Tucker invaluable strategic partners in navigating the commercial risk and uncertainty inherent in new drug development. They harness the collective wisdom of the market, sort out conflicting opinions and biases, and provide clear direction on complex clinical and commercial decisions.”
— PAUL SEKHRI, PRESIDENT AND CEO, LYCERA CORP.